Literature DB >> 30854579

Treatment of Central Nervous System Complications of Renal Dialysis and Transplantation.

Samer Dahdaleh1,2, Paresh Malhotra3,4.   

Abstract

PURPOSE OF REVIEW: Most clinical neurologists will have come across individuals receiving renal replacement therapy who have developed a neurological complication, and neurologists working in, or close to, hospitals with a Renal Unit will be very aware of the range of central nervous system (CNS) complications that may develop in these patients. These can often be difficult to differentiate from disorders relating to renal failure or systemic conditions leading to kidney disease and can in fact arise from the interaction between underlying disease and the side effects of treatment. Patients with renal disease frequently have multiple comorbidities, and it is necessary to take a generally inclusive approach to diagnosis and treatment. RECENT
FINDINGS: Unfortunately, there is a lack of specific high-quality evidence for a number of CNS complications of renal replacement therapy. Here, we review the major CNS complications of dialysis and transplantation, discussing evidence for treatments where available and detailing standard management approaches where evidence is scarce. Given the lack of specific evidence for interventions in the treatment of CNS complications of renal replacement therapy, it is often necessary to take an individualised approach based on comorbidities and applying findings from the general population. In these complex patients, we must stress the importance of collaborative working between neurologists and renal physicians when treating this complex patient group.

Entities:  

Keywords:  Central nervous system complications; Dialysis; Renal replacement therapy; Renal transplant

Year:  2019        PMID: 30854579     DOI: 10.1007/s11940-019-0553-6

Source DB:  PubMed          Journal:  Curr Treat Options Neurol        ISSN: 1092-8480            Impact factor:   3.598


  61 in total

Review 1.  Use of antiepileptic drugs in patients with kidney disease.

Authors:  Rubeen K Israni; Nishaminy Kasbekar; Kevin Haynes; Jeffrey S Berns
Journal:  Semin Dial       Date:  2006 Sep-Oct       Impact factor: 3.455

2.  Improvement of dialysis headache after treatment with ACE-inhibitors but not angiotensin II receptor blocker: a case report with pathophysiological considerations.

Authors:  E Leinisch-Dahlke; T Schmidt-Wilcke; B K Krämer; A May
Journal:  Cephalalgia       Date:  2005-01       Impact factor: 6.292

3.  Stroke in patients on maintenance hemodialysis: a 22-year single-center study.

Authors:  Kazunori Toyoda; Kenichiro Fujii; Satoru Fujimi; Yasuhiro Kumai; Hirohito Tsuchimochi; Setsuro Ibayashi; Mitsuo Iida
Journal:  Am J Kidney Dis       Date:  2005-06       Impact factor: 8.860

4.  Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients.

Authors: 
Journal:  BMJ       Date:  2002-01-12

5.  Atorvastatin in patients with type 2 diabetes mellitus undergoing hemodialysis.

Authors:  Christoph Wanner; Vera Krane; Winfried März; Manfred Olschewski; Johannes F E Mann; Günther Ruf; Eberhard Ritz
Journal:  N Engl J Med       Date:  2005-07-21       Impact factor: 91.245

6.  Elevated risk of stroke among patients with end-stage renal disease.

Authors:  Stephen L Seliger; Daniel L Gillen; W T Longstreth; Bryan Kestenbaum; Catherine O Stehman-Breen
Journal:  Kidney Int       Date:  2003-08       Impact factor: 10.612

7.  Variations in the risk for cerebrovascular events after kidney transplant compared with experience on the waiting list and after graft failure.

Authors:  Krista L Lentine; Lisa A Rocca Rey; Swathy Kolli; Giuliana Bacchi; Mark A Schnitzler; Kevin C Abbott; Huiling Xiao; Daniel C Brennan
Journal:  Clin J Am Soc Nephrol       Date:  2008-04-02       Impact factor: 8.237

Review 8.  Blood pressure reduction and secondary prevention of stroke and other vascular events: a systematic review.

Authors:  Parveen Rashid; Jo Leonardi-Bee; Philip Bath
Journal:  Stroke       Date:  2003-10-23       Impact factor: 7.914

9.  Effect of fluvastatin on cardiac outcomes in renal transplant recipients: a multicentre, randomised, placebo-controlled trial.

Authors:  Hallvard Holdaas; Bengt Fellström; Alan G Jardine; Ingar Holme; Gudrun Nyberg; Per Fauchald; Carola Grönhagen-Riska; Søren Madsen; Hans-Hellmut Neumayer; Edward Cole; Bart Maes; Patrice Ambühl; Anders G Olsson; Anders Hartmann; Dag O Solbu; Terje R Pedersen
Journal:  Lancet       Date:  2003-06-14       Impact factor: 79.321

10.  Aspirin prescription and outcomes in hemodialysis patients: the Dialysis Outcomes and Practice Patterns Study (DOPPS).

Authors:  Jean Ethier; Jennifer L Bragg-Gresham; Luis Piera; Tadao Akizawa; Yasushi Asano; Nancy Mason; Brenda W Gillespie; Eric W Young
Journal:  Am J Kidney Dis       Date:  2007-10       Impact factor: 8.860

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.